Feedback / Questions
Gohibic (vilobelimab) - Staidson Biopharma, InflaRx
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT04812535
May 3, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next